Merck Provides Update on Phase III Clinical Program for Preladenant

News   May 24, 2013

 
Merck Provides Update on Phase III Clinical Program for Preladenant
 
 
 

RELATED ARTICLES

Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the Body

News

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.

READ MORE

Transplanting Stem Cells directly into the Cerebrospinal Fuid Reduces the Amount of Succinate, Reprograms Macrophages and Microglia

News

Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis (MS).

READ MORE

New Neurons Generated in Adult Brains Are Important for Sensory Learning

News

Scientists have demonstrated that the new neurons produced in adults react preferentially to reward-related sensory stimuli and help speed up the association between sensory information and reward.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE